Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sjors Klompmaker

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Annals of Surgical Oncology|December 20, 2022
Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort StudyEran van Veldhuisen, Sjors Klompmaker, Quisette P Janssen, et al.
JAMA Oncology|September 10, 2020
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX TreatmentStijn van Roessel, Eran van Veldhuisen, Sjors Klompmaker, et al.
Annals of Surgery|December 15, 2017
Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External ValidationTimothy H Mungroop, L Bengt van Rijssen, David van Klaveren, et al.
Annals of Surgery|November 4, 2017
Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched StudyJony van Hilst, Thijs de Rooij, Sjors Klompmaker, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Annals of Surgical Oncology|December 20, 2022
Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort StudyEran van Veldhuisen, Sjors Klompmaker, Quisette P Janssen, et al.
JAMA Oncology|September 10, 2020
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX TreatmentStijn van Roessel, Eran van Veldhuisen, Sjors Klompmaker, et al.
Annals of Surgery|December 15, 2017
Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External ValidationTimothy H Mungroop, L Bengt van Rijssen, David van Klaveren, et al.
Annals of Surgery|November 4, 2017
Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched StudyJony van Hilst, Thijs de Rooij, Sjors Klompmaker, et al.
Pageof 3